A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...

Printer-friendly versionSend by emailPDF version

Name

Genetech, Incorporated

Anticipated Amount

256 354.00

Activity Type

Clinical Trial

Award Type

Contract

Date

July 14, 2012 to October 1, 2014

Award Number

005746-00001

Sponsor Award Number

MO27782

Award Contacts

Name

Stopeck,Alison T

Title

Principal Investigator

Unit

Cancer Center Division

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona